Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial
Stroke · 2026
DOI: 10.1161/strokeaha.125.052545 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2026. Verfasst von Alexander Martin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.). Hauptthemen laut MEDLINE: Stroke Rehabilitation, Stroke, Motivation. Die Arbeit nennt 21 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: The Take Charge intervention—a conversation-based, community intervention to improve motivation, improved independence, and physical health 12 months after stroke in 2 randomized controlled trials with 572 participants. This article reports long-term outcomes for the 400 participants in the TaCAS study (Taking Charge After Stroke). METHODS: Follow-up study of a New Zealand multicenter, randomized, controlled, parallel-group trial. Outcomes were collected by postal questionnaire or telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomized within 16 weeks to one of 3 groups: 1 session of the Take Charge intervention, 2 sessions 6 weeks apart, or no sessions (control). This study is of participants still alive and willing to answer a questionnaire 5 to 6 years after their index stroke, undertaken in 2022. The primary outcome was the Physical Component Summary of the Short Form 36, comparing the Take Charge intervention and control. Secondary outcomes were: Frenchay Activities Index; modified Rankin Scale (mRS); survival; and stroke recurrence. These outcomes were compared with those 12 months after stroke. Analysis was by ANOVA or logistic regression. RESULTS: Mortality data were available for all 400 participants, and functional data for 204/297 (69%) of survivors. The mean difference (95% CI) in Physical Component Summary between Take Charge and control groups was 2.8 (−0.8 to 6.5) units, P =0.12, and for independence (modified Rankin Scale score, 0–2) the odds ratio (95% CI) was 0.56 (0.28–1.16), P =0.11, both favoring Take Charge with similar point estimates to those after 12 months. Differences between Take Charge and control participants for Frenchay Activities Index scores, survival, and stroke recurrence were small and nonsignificant. CONCLUSIONS: The clinically significant improvements in physical health and independence for Take Charge participants, observed at 12 months, were sustained 5 to 6 years after stroke, but no longer statistically significant. REGISTRATION: URL: https://anzctr.org.au ; Unique identifier: ACTRN12622000311752.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Research Institute of New Zealand, Wellington (A.M., V.F., Z.J., S.J., A.E., G.S., A.S., H.M.N.).
- University of Calgary, ON, Canada (V.F.).
- University of Otago, Wellington, New Zealand (M.W.).
- Victoria University of Wellington, New Zealand (G.S.).
- Hawke's Bay Hospital, Hastings, New Zealand (J.G.).
ORCID-Profile: Alexander Martin, Vivian Fu, Zamir Joya, Sajida Joya, Mark Weatherall, Alex Semprini, John Gommans, Harry McNaughton
Zitieren
APA
Martin, A., Fu, V., Joya, Z., Joya, S., Eathorne, A., Weatherall, M., Shortt, G., Semprini, A., Gommans, J., & McNaughton, H. (2026). Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial. Stroke. https://doi.org/10.1161/strokeaha.125.052545
Vancouver
Martin A, Fu V, Joya Z, Joya S, Eathorne A, Weatherall M, et al. Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial. Stroke. 2026. doi:10.1161/strokeaha.125.052545
BibTeX
@article{Martin2026,
author = {Martin, Alexander and Fu, Vivian and Joya, Zamir and Joya, Sajida and Eathorne, Allie and Weatherall, Mark and Shortt, Gabrielle and Semprini, Alex and Gommans, John and McNaughton, Harry},
title = {Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial},
journal = {Stroke},
year = {2026},
doi = {10.1161/strokeaha.125.052545}
}
EUVIMED